App-Quantinova.ai

Improving patient care in psoriatic arthritis through quality improvement and audit against the National Institute for Health and Care Excellence NG65 guidelines

Elena J Papadopoulos - British Society for Rheumatology (BSR) , 2020

Therapeutic Area

Disease

Drug/Treatment

Dermatology

Psoriatic arthritis

N/A

The impact of patient’s compliance and delivery delays: a cost-saving audit on biologics

Patra Pookarnjanamorakot - British Society for Rheumatology (BSR) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

Audit of anti-nuclear antibody testing in East Kent and the British Society for Rheumatology Choosing Wisely recommendations

Sheraz Rasool - British Society for Rheumatology (BSR) , 2020

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Inflammatory Arthritis

N/A

Rapid-access temporal artery ultrasound by vascular sonographers in suspected GCA: an audit during and after a training phase

Laura Devonshire - British Society for Rheumatology (BSR) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

Review of pregnancy outcomes in patients with ankylosing spondylitis presenting to the Bart's Health High Risk Antenatal clinic: results of clinical audit and recommendations

Mohammad Khudadah - British Society for Rheumatology (BSR) , 2020

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Ankylosing spondylitis

N/A

Clinical responses, B cell depletion and treatment outcomes following rituximab biosimilar switch in RA: is there value in switching back?

Andrew Melville - British Society for Rheumatology (BSR) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

Rituximab biosimilar

An analysis of multidisciplinary care in systemic auto-immune rheumatic disease in a single centre

Kieran Sandhu - British Society for Rheumatology (BSR) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

Using NHS resources wisely: A Snapshot of biologic and small molecule agent prescribing at the Peter Maddison Rheumatology Centre

Alaw R Jones - British Society for Rheumatology (BSR) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

An audit of the management of Behçet's disease in a tertiary referral centre against guidelines from EULAR and the National Centres of Excellence

Jessica Weightman - British Society for Rheumatology (BSR) , 2020

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Behcet disease

N/A

Orthoptic led eye screening co-located within the paediatric rheumatology clinic for safer management of children with JIA

Aicha Bouraoui - British Society for Rheumatology (BSR) , 2020

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

Uveitis

N/A

Prediction of response of methotrexate in patients with rheumatoid arthritis using serum lipidomics

Mateusz Maciejewski - British Society for Rheumatology (BSR) , 2020

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Methotrexate

Investigating the role of rare genetic variants and susceptibility to juvenile idiopathic arthritis highlights the importance of monogenic disease genes

Melissa K Tordoff - British Society for Rheumatology (BSR) , 2020

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

N/A

Frequencies of IL-17+CD8+ T-cells and tissue resident memory T-cells in early inflammatory arthritis

Catherine D Hughes - British Society for Rheumatology (BSR) , 2020

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Early inflammatory arthritis

lonomycin

The identification of novel genetic susceptibility loci for juvenile idiopathic arthritis by analysis across clinical subgroups

John Bowes - British Society for Rheumatology (BSR) , 2020

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

N/A

Novel ex-vivo model of septic arthritis identifies role of neutrophils in joint destruction and identifies a potential biomarker for diagnosis

Kathryn E McCall - British Society for Rheumatology (BSR) , 2020

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Infectious arthritis

N/A

Micro-RNA enriched pathway impact analysis applied to synovial RNA-seq in early rheumatoid arthritis identifies response prediction pathways

Elisabetta Sciacca - British Society for Rheumatology (BSR) , 2020

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

N/A

Adult onset Still’s disease as a novel autoimmune complication of alemtuzumab therapy: a case report and review of alemtuzumab associated autoimmune disease

Nehal Narayan - British Society for Rheumatology (BSR) , 2020

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Adult onset Still's disease

Alemtuzumab

The successful use of anakinra to control protracted immune reconstitution inflammatory syndrome in HIV associated tuberculosis: a report of two cases

Alexander J Keeley - British Society for Rheumatology (BSR) , 2020

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Tuberculosis

Anakinra

Erdheim-Chester disease: a rare histocytosis masked as IgG4 disease

Dhivya Das - British Society for Rheumatology (BSR) , 2020

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Erdheim-Chester disease

N/A

Case of atypical cutaneous Mycobacterium chelonae infection in a patient with SLE after cyclophosphamide therapy

Sheraz Rasool - British Society for Rheumatology (BSR) , 2020

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Peripheral neuropathy

Cyclophosphamide

Filters

45280 Abstracts